As the only global women’s healthcare company of its kind, Organon is well positioned to help address several current and growing women’s health challenges. Through the Organon Her Promise Access Initiative, Organon is working with global organizations to provide family planning information, education and access to low-cost contraceptive options. To redefine and harness innovation in women’s health . Currently, Organon’s Board is the most diverse healthcare board on the S&P 500. Currently, Organon’s Board is the most diverse healthcare board on the S&P 500.

Source: The North Africa Journal June 03, 2022 09:29 UTC